V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007516 | 220002963 | 1.62 | 74.3 | Curative (C) | 2013-10-11 | 2013-10-13 | AML 18 TRIAL | N | N | 220032602 | AML18 TRIAL |
| 220007517 | 220002964 | 1.64 | 92 | Curative (C) | 2015-12-01 | 2015-12-06 | CARBOPLATIN + PACLITAXEL | N | N | 220032603 | CARBOPLATIN + PACLITAXEL |
| 220007518 | 220002964 | null | 75 | Curative (C) | 2017-03-26 | 2017-04-27 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032603 | CARBOPLATIN + PACLITAXEL |
| 220007519 | 220002965 | 1.71 | 85.1 | Curative (C) | 2017-12-17 | 2017-11-20 | CARBOPLATIN + PACLITAXEL | N | N | 220032607 | CARBOPLATIN + PACLITAXEL |
| 220007520 | 220002966 | null | 90.6 | Curative (C) | 2016-01-31 | 2016-01-31 | AML18 PILOT TRIAL | Y | N | 220032608 | PILOT TRIAL |
| 220007521 | 220002966 | null | 94.7 | Curative (C) | 2016-11-10 | 2016-11-17 | AML18 PILOT TRIAL | Y | null | 220032608 | PILOT TRIAL |
| 220007522 | 220002967 | 1.8 | 0 | Curative (C) | 2015-08-18 | 2015-08-18 | Dasatinib | 2 | N | 220032610 | DASATINIB |
| 220007523 | 220011667 | 1.79 | 93 | Palliative (P) | 2012-12-10 | 2013-08-10 | Dasatinib | N | N | 220032611 | DASATINIB |
| 220007526 | 220002969 | 1.69 | 78 | Curative (C) | 2017-06-05 | 2017-06-07 | AML 18 TRIAL | 01 | null | 220032617 | AML18 TRIAL |
| 220007527 | 220002969 | null | 94 | Curative (C) | 2014-12-31 | 2015-01-01 | AML18 PILOT TRIAL | Y | N | 220032617 | PILOT TRIAL |
| 220007530 | 220002970 | 1.8 | 74.9 | Curative (C) | 2017-10-12 | 2017-10-12 | AML16 DA 3+10 | N | N | 220032624 | AML16 TRIAL |
| 220007531 | 220002970 | 1.56 | 64 | Palliative (P) | 2016-12-02 | 2017-01-15 | CISPLATIN + GEMCITABINE | N | N | 220032624 | CISPLATIN + GEMCITABINE |
| 220007532 | 220002970 | 1.49 | 84 | Curative (C) | null | 2013-05-22 | AML16 DA 3+10 | N | N | 220032624 | AML16 TRIAL |
| 220007533 | 220002970 | null | 93.2 | Palliative (P) | 2013-09-17 | 2013-09-18 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032624 | CISPLATIN + GEMCITABINE |
| 220007534 | 220002970 | null | null | Palliative (P) | 2017-08-17 | 2017-10-04 | Cisplatin+Gemcitabine (gallbladder) | null | N | 220032624 | CISPLATIN + GEMCITABINE |
| 220007535 | 220002970 | null | 77.8 | null | 2015-02-11 | 2015-02-19 | CARBOPLATIN + GEMCITABINE | N | null | 220032624 | GEMCARBO |
| 220007536 | 220002971 | 1.85 | 83.7 | Palliative (P) | 2017-10-05 | 2017-10-12 | CISPLATIN + GEMCITABINE | N | N | 220032632 | CISPLATIN + GEMCITABINE |
| 220007537 | 220002972 | 1.59 | 68.2 | Curative (C) | null | 2013-12-23 | AML16 DA 3+8 | Y | N | 220032635 | AML16 TRIAL |
| 220007538 | 220002973 | 1.5 | 53.8 | null | null | 2015-11-21 | IDARUBICIN + TRETINOIN | N | N | 220032637 | IDARUBICIN + TRETINOIN |
| 220007539 | 220002973 | -1 | 81.1 | Disease modification (D) | 2017-08-26 | 2018-04-28 | Dasatinib | N | null | 220032637 | DASATINIB |
| 220007540 | 220002973 | 1.63 | 72.2 | Curative (C) | 2013-10-04 | 2013-10-11 | AML18 PILOT TRIAL | N | N | 220032637 | PILOT TRIAL |
| 220007541 | 220002973 | 1.78 | 74.7 | null | 2013-10-30 | 2013-12-12 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 220032637 | CISPLATIN + GEMCITABINE |
| 220007542 | 220002973 | 1.61 | 72 | Curative (C) | null | 2015-07-14 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032637 | CARBOPLATIN + PACLITAXEL |
| 220007543 | 220002973 | null | 74 | Palliative (P) | 2017-07-21 | 2017-08-05 | GemCarbo Days 1+8 | 02 | null | 220032637 | GEMCARBO |
| 220007544 | 220002973 | 1.58 | null | Curative (C) | null | 2016-08-31 | IDARUBICIN + TRETINOIN | N | N | 220032637 | IDARUBICIN + TRETINOIN |
| 220007545 | 220002973 | 0 | 71.1 | Curative (C) | 2013-09-04 | 2013-09-05 | Dasatinib | 02 | N | 220032637 | DASATINIB |
| 220007546 | 220002974 | 1.81 | 92.1 | Curative (C) | 2017-07-18 | 2017-07-25 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220032653 | CARBOPLATIN + PACLITAXEL |
| 220007547 | 220002975 | 1.82 | 79.5 | Palliative (P) | 2016-08-10 | 2016-08-18 | CARBOPLATIN + GEMCITABINE | 02 | N | 220032654 | GEMCARBO |
| 220007548 | 220002976 | 1.58 | 55.6 | Curative (C) | 2015-09-13 | 2015-09-23 | AML18 PILOT TRIAL | Y | N | 220032655 | PILOT TRIAL |
| 220007549 | 220002977 | 1.67 | 70.2 | Palliative (P) | 2014-09-15 | 2014-10-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032656 | CISPLATIN + GEMCITABINE |
| 220007550 | 220002978 | 0 | 90 | null | 2014-11-15 | 2014-11-15 | CISPLATIN + GEMCITABINE | null | N | 220032657 | CISPLATIN + GEMCITABINE |
| 220007551 | 220002979 | 1.63 | 59 | Not known (9) | 2017-09-20 | 2017-09-20 | IDARUBICIN + TRETINOIN | 02 | N | 220032658 | IDARUBICIN + TRETINOIN |
| 220007552 | 220002980 | 1.79 | 89.6 | Palliative (P) | 2016-02-17 | 2016-02-24 | CARBOPLATIN + GEMCITABINE | 02 | N | 220032660 | GEMCARBO |
| 220007553 | 220002981 | null | 144 | Curative (C) | 2016-10-06 | 2016-10-07 | AML 18 TRIAL | N | N | 220032662 | AML18 TRIAL |
| 220007554 | 220002982 | null | 108.7 | Curative (C) | 2016-12-22 | 2017-02-02 | AML 18 TRIAL | N | N | 220032665 | AML18 TRIAL |
| 220007555 | 220011672 | null | 95 | Curative (C) | 2016-03-14 | 2016-03-16 | Idarubicin+Tretinoin Spanish Crse4 | 02 | null | 220032666 | IDARUBICIN + TRETINOIN |
| 220007556 | 220002983 | 1.58 | 63 | Curative (C) | 2015-11-21 | 2015-11-25 | Dasatinib | 2 | N | 220032669 | DASATINIB |
| 220007559 | 220016280 | 1.69 | null | null | 2018-04-25 | 2018-05-10 | CARBOPLATIN + GEMCITABINE | N | N | 220032676 | GEMCARBO |
| 220007560 | 220002985 | 1.77 | null | null | null | 2016-01-20 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220032678 | IDARUBICIN + TRETINOIN |
| 220007561 | 220002986 | 1.55 | 76 | null | 2014-02-24 | 2014-03-01 | GEMCARBO | N | N | 220032681 | GEMCARBO |
| 220007562 | 220011674 | 1.84 | 0 | Palliative (P) | null | 2016-05-30 | AML16 DA 3+10 | Y | N | 220032682 | AML16 TRIAL |
| 220007563 | 220002987 | 1.7 | null | Palliative (P) | 2014-08-16 | 2014-08-23 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 220032685 | CISPLATIN + GEMCITABINE |
| 220007564 | 220011675 | 1.7 | 59 | null | 2016-06-29 | 2016-07-02 | GemCarbo Days 1+8 | N | N | 220032687 | GEMCARBO |
| 220007565 | 220016281 | 1.83 | 70.4 | Disease modification (D) | 2016-02-03 | 2016-02-05 | Dasatinib | N | N | 220032692 | DASATINIB |
| 220007566 | 220018913 | 1.64 | 53.9 | Curative (C) | null | 2013-05-06 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032694 | CARBOPLATIN + PACLITAXEL |
| 220007567 | 220018913 | 1.6 | 72 | Curative (C) | 2013-10-08 | 2013-10-21 | AML16 DA 3+10 | 02 | N | 220032694 | AML16 TRIAL |
| 220007568 | 220002988 | 1.6 | 62 | Curative (C) | 2015-10-27 | 2015-10-30 | IDARUBICIN + TRETINOIN | Y | N | 220032698 | IDARUBICIN + TRETINOIN |
| 220007569 | 220002988 | 1.61 | 68.3 | Curative (C) | 2015-05-16 | 2015-05-16 | IDARUBICIN + TRETINOIN | null | null | 220032698 | IDARUBICIN + TRETINOIN |
| 220007570 | 220002988 | 0 | 58.2 | Curative (C) | 2017-08-05 | 2017-08-06 | AML 18 TRIAL | 01 | N | 220032698 | AML18 TRIAL |
| 220007571 | 220002988 | 1.7 | 47.5 | Palliative (P) | 2017-05-30 | 2018-06-01 | Dasatinib | 2 | N | 220032698 | DASATINIB |